Literature DB >> 20598018

The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the α7 nicotinic receptor.

Andrew T Seipel1, Jerrel L Yakel.   

Abstract

Voltammetric analyses show that low (100-500 nM) doses of nicotine regulate striatal dopamine by inhibiting release evoked by a single stimulation to a greater extent than release evoked by high frequency stimulations. This frequency-dependent inhibition is because of nicotine desensitizing heteromeric β2 subunit-containing nicotinic acetylcholine receptor (nAChR) subtypes. Surprisingly, a high dose of nicotine (2 μM; capable of interacting with additional nAChR subtypes) produced an inhibition of dopamine evoked by high frequency stimulation, an effect that was not seen with the low dose of nicotine or the β2 antagonist, dihydro-β-erythroidine hydrobromide. This inhibition was replicated by application of α7 nAChR antagonists methyllcaconitine citrate or α-bungarotoxin in conjunction with the low dose of nicotine or dihydro-β-erythroidine hydrobromide. Blocking α7 receptor function alone produced a modest increase in dopamine evoked by single pulse stimulation while not affecting dopamine evoked by high frequency stimulation. The antagonist results were mimicked using selective α7 agonists PHA 543613 and PNU 282987. The frequency dependence of the low dose nicotine inhibition therefore requires functional α7 nAChRs, and may arise from differing levels of endogenous acetylcholine evoked by the stimulation. Journal Compilation
© 2010 International Society for Neurochemistry. No claim to original US government works.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598018      PMCID: PMC2945408          DOI: 10.1111/j.1471-4159.2010.06883.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat.

Authors:  D Clark; L A Chiodo
Journal:  Synapse       Date:  1988       Impact factor: 2.562

2.  Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum.

Authors:  F M Zhou; Y Liang; J A Dani
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

3.  Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.

Authors:  Q Wu; M E Reith; R M Wightman; K T Kawagoe; P A Garris
Journal:  J Neurosci Methods       Date:  2001-12-15       Impact factor: 2.390

Review 4.  Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

Authors:  D M Morens; A Grandinetti; D Reed; L R White; G W Ross
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

Review 5.  DAncing past the DAT at a DA synapse.

Authors:  Stephanie J Cragg; Margaret E Rice
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

6.  Nicotine amplifies reward-related dopamine signals in striatum.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

7.  Frequency-dependent modulation of dopamine release by nicotine.

Authors:  Hui Zhang; David Sulzer
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

8.  Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.

Authors:  Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis J David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco M Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

9.  Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions.

Authors:  W Schultz; R Romo
Journal:  J Neurophysiol       Date:  1990-03       Impact factor: 2.714

10.  Smoking and Parkinson's disease: a dose-response relationship.

Authors:  J M Gorell; B A Rybicki; C C Johnson; E L Peterson
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  6 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Frequency-Dependent Modulation of Dopamine Release by Nicotine and Dopamine D1 Receptor Ligands: An In Vitro Fast Cyclic Voltammetry Study in Rat Striatum.

Authors:  W Goutier; J P Lowry; A C McCreary; J J O'Connor
Journal:  Neurochem Res       Date:  2016-03-15       Impact factor: 3.996

3.  Modulation of aggressive behavior in mice by nicotinic receptor subtypes.

Authors:  Alan S Lewis; Yann S Mineur; Philip H Smith; Emma L M Cahuzac; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

Review 4.  Dopamine release in the basal ganglia.

Authors:  M E Rice; J C Patel; S J Cragg
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

5.  Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.

Authors:  Nigel M Williams; Barbara Franke; Eric Mick; Richard J L Anney; Christine M Freitag; Michael Gill; Anita Thapar; Michael C O'Donovan; Michael J Owen; Peter Holmans; Lindsey Kent; Frank Middleton; Yanli Zhang-James; Lu Liu; Jobst Meyer; Thuy Trang Nguyen; Jasmin Romanos; Marcel Romanos; Christiane Seitz; Tobias J Renner; Susanne Walitza; Andreas Warnke; Haukur Palmason; Jan Buitelaar; Nanda Rommelse; Alejandro Arias Vasquez; Ziarih Hawi; Kate Langley; Joseph Sergeant; Hans-Christoph Steinhausen; Herbert Roeyers; Joseph Biederman; Irina Zaharieva; Hakon Hakonarson; Josephine Elia; Anath C Lionel; Jennifer Crosbie; Christian R Marshall; Russell Schachar; Stephen W Scherer; Alexandre Todorov; Susan L Smalley; Sandra Loo; Stanley Nelson; Corina Shtir; Philip Asherson; Andreas Reif; Klaus-Peter Lesch; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

6.  Chromosome 15 Duplication and Attention-Deficit Hyperactivity Disorder.

Authors:  Sundar Gnanavel
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.